How Charcoal Tablets Work in Dogs Charcoal tablets–also known as activated charcoal or medicinal charcoal–have been trusted ...

New LEQEMBI CompanionTM program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide patients with injection training, and an ...

GULF SHORES, Ala. (WALA) - A man Gulf Shores Police have been looking for over the last month is now behind bars on a robbery charge. We first told you about Brandon Demarcus Harris last month and ...

The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. With ...

The FDA has approved Merck & Co.’s under-the-skin version of Keytruda, reducing treatment time burden for patients while granting the world’s bestselling drug potential blockbuster revenue protection.

FDA approved pembrolizumab and berahyaluronidase alfa-pmph for patients aged 12 and older with solid tumors. Study MK-3475A-D77 showed a 45% ORR in subcutaneous administration for treatment-naïve ...

Ohio Paws with Purpose, a nonprofit pet food pantry, will provide dog and cat food to over 100 families in need from 10 to 11:30 a.m. Sept. 22 at the Fairport Harbor Senior Center, 1380 East St. Dry ...

It’s jarring to wake up covered in hives or fighting sneezes after years of never thinking twice about your dog. Allergies don’t always show up early; they can slip into your life without warning. The ...

The FDA has approved a subcutaneous formulation of lecanemab (Leqembi Iqlik, Eisai/Biogen) for maintenance dosing in patients with Alzheimer’s disease (AD) with mild cognitive impairment (MCI) or mild ...

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous (IV) phase. Leqembi Iqlik is a subcutaneous ...

STOCKHOLM, Aug. 29, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA-B) partner Eisai announced today the U.S. Food and Drug Administration (FDA) has approved the Biologics License ...